Mednax Inc. (
Q4 2011 Earnings Call
February 02, 2012 10:00 am ET
David Parker – Vice President of Investor Relations
Roger J. Medel, M.D. – Chief Executive Officer
Vivian Lopez-Blanco – Chief Financial Officer
Kevin Fischbeck – Bank of America Merrill Lynch
Kevin Ellich – Piper Jaffray
Darren Lehrich – Deutsche Bank Securities Inc.
Brooks O'Neil – Dougherty & Company
Gary Taylor – Citigroup
Ryan Daniels – William Blair & Co. LLC
Robert M. Mains – Morgan Keegan & Co., Inc.
Ralph Giacobbe – Credit Suisse
Arthur Henderson – Jefferies & Company, Inc.
Matt Weight – Feltl & Company
Ladies and gentlemen, thank you very much for standing by. Welcome to today’s 2011 fourth quarter earnings release conference call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session with instructions given at that time. (Operator Instructions) As a reminder, today’s conference is being recorded.
And I’d now like to turn the conference over to our host today, Vice President of Investor Relations and Corporate Communications, Mr. David Parker. Please go ahead, sir.
Thank you and good morning to MEDNAX’s 2011 fourth quarter earnings call. Certain statements and information during this conference call may contain forward-looking statements. These forward-looking statements are based on assumptions and assessments made by MEDNAX's management in light of their experience and their perception of historical trends, current conditions, expected future developments and other factors they believe to be appropriate.
Any forward-looking statements made during this call are made as of today, and MEDNAX undertakes no duty to update or revise any such statements whether as a result of new information, future events or otherwise. Important factors that could cause actual results, developments and business decisions to differ materially from forward-looking statements are described in the company's most recent annual report on Form 10-K and its quarterly reports on Form 10-Q including the sections entitled Risk Factors.